thiazoles has been researched along with Pulmonary Hypertension in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 27 (81.82) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Long, J; Peng, G; Xiao, P; Yang, H; Zeng, X | 1 |
| Ivanovska, J; Jain, A; Jankov, RP; Kantores, C; Post, M; Shah, S; Wong, MJ; Yeganeh, B | 1 |
| Emoto, N; Hirata, KI; Nakayama, K; Okano, M; Okita, Y; Onishi, H; Shinke, T; Shinkura, Y; Tamada, N; Tanaka, H; Yanaka, KI | 1 |
| Kim, DH; Kim, JC; Kim, SH; Kwan, J; Park, KS; Shin, SH; Woo, SI; Yi, HG | 1 |
| Hao, P; Li, R; Li, X; Li, Y; Liu, G; Sun, Y; Tang, X; Xu, J | 1 |
| Betkier-Lipińska, K; Cwetsch, A; Góra-Tybor, J; Ryczek, R | 1 |
| Humbert, M; Jardim, C; Souza, R | 1 |
| Bergot, E; Godinas, L; Guignabert, C; Humbert, M; Montani, D; Perros, F; Seferian, A; Sibille, Y | 1 |
| Álvarez Álvarez, CM; Buchelli Ramirez, HL; Casan Clarà, P; García Clemente, MM; Rodríguez Reguero, JJ | 1 |
| Anwer, F; Vincelette, ND; Yun, S | 1 |
| Liu, B; Mi, Y; Wang, J; Wang, Y | 1 |
| Çengel, A; Özkurt, ZN; Taçoy, G; Türkoğlu, S | 1 |
| Lee, CS; Liu, TC; Wang, HC | 1 |
| Atlı, Ö; Burukoğlu, D; Ergun, B; Ilgın, S; Musmul, A; Sırmagül, B | 1 |
| Agüero, J; Barberá, JA; Campelos, P; Castellá, M; Fernández-Friera, L; Fernández-Jiménez, R; Fuster, V; García-Álvarez, A; García-Lunar, I; García-Prieto, J; García-Ruiz, JM; Ibañez, B; Nuño-Ayala, M; Peinado, VI; Pereda, D; Pizarro, G; Sabaté, M; Sandoval, E; Santiago, E; Sanz-Rosa, D; Sierra, F | 1 |
| Flaim, B; Rasheed, W; Seymour, JF | 1 |
| Feola, M; Gallamini, A; Mattei, D; Mordini, N; Orzan, F; Rapezzi, D | 1 |
| Desvergne, B; Garland, C; Harrington, LS; Mitchell, JA; Moreno, L; Reed, A; Wort, SJ; Zhao, L | 1 |
| Dahal, BK; Ghofrani, HA; Grimminger, F; Kast, R; Kosanovic, D; Lai, YJ; Pamarthi, PK; Schermuly, RT; Schirok, H; Seeger, W; Stasch, JP; Sydykov, A; Weissmann, N | 1 |
| Baumann, HJ; Bokemeyer, C; Brümmendorf, TH; Hennigs, JK; Honecker, F; Keller, G; Klose, H; Kluge, S | 1 |
| Dumitrescu, D; Erdmann, E; Gerhardt, F; Rosenkranz, S; Seck, C; ten Freyhaus, H | 1 |
| Dinh-Xuan, AT; Humbert, M; Simonneau, G | 1 |
| Ghio, S; Orlandi, EM; Pazzano, AS; Rocca, B | 1 |
| Force, T | 1 |
| Bergeron, A; Bergot, E; Bourdin, A; Bouvaist, H; Canuet, M; Girerd, B; Guignabert, C; Günther, S; Humbert, M; Jaïs, X; Macro, M; Montani, D; Natali, D; O'Callaghan, DS; Perros, F; Pison, C; Poubeau, P; Savale, L; Simonneau, G; Sitbon, O; Tubert-Bitter, P; Zalcman, G | 1 |
| Berghausen, EM; Brandes, RP; Butrous, E; Butrous, G; Dabral, S; Dahal, BK; Ghofrani, HA; Grimminger, F; Pullamsetti, SS; Rosenkranz, S; Savai, R; Schermuly, RT; Seeger, W; Tretyn, A; Weissmann, N | 1 |
| Chen, J; Li, S; Lu, P; Ma, C; Ran, Y; Shi, S; Zhang, D; Zhu, D | 1 |
| Hayashi, H; Katoh, H; Ohnishi, K; Sano, M; Saotome, M; Satoh, H; Urushida, T | 1 |
| Ayon, RJ; Davis, AJ; Duan, DD; Forrest, AS; Freitas, N; Greenwood, IA; Huebner, ML; Joyce, J; Joyce, TC; Leblanc, N; Singer, CA; Valencik, ML; Wiwchar, M; Ye, L | 1 |
| Ambalavanan, N; Bulger, A; Chen, YF; Oparil, S; Philips, JB | 1 |
| Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T; Takahashi, T | 2 |
2 review(s) available for thiazoles and Pulmonary Hypertension
| Article | Year |
|---|---|
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
Topics: Apoptosis; Benzamides; Cell Proliferation; Dasatinib; Endothelial Cells; ErbB Receptors; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Fibroblasts; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Niacinamide; Phenylurea Compounds; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pulmonary Circulation; Pyrimidines; Receptor Protein-Tyrosine Kinases; Sorafenib; src-Family Kinases; Thiazoles; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
[Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].
Topics: Dasatinib; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Prognosis; Pyrimidines; Thiazoles; Young Adult | 2014 |
31 other study(ies) available for thiazoles and Pulmonary Hypertension
| Article | Year |
|---|---|
Protective effects of resveratrol and SR1001 on hypoxia-induced pulmonary hypertension in rats.
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Hypertension, Pulmonary; Hypoxia; Male; Protein Phosphatase 1; Pulmonary Artery; Rats; Resveratrol; rhoA GTP-Binding Protein; Sulfonamides; Th17 Cells; Thiazoles; Treatment Outcome | 2020 |
mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy.
Topics: Animals; Animals, Newborn; Autophagy; Cell Proliferation; Diamines; Female; Hypertension, Pulmonary; Hypoxia; Lung; Male; Myocytes, Smooth Muscle; Pulmonary Artery; Rats, Sprague-Dawley; Receptor, Notch3; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Sirolimus; Thiazoles; TOR Serine-Threonine Kinases | 2017 |
Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cerebral Infarction; Chronic Disease; Endarterectomy; Heparin; Humans; Hypertension, Pulmonary; Male; Parkinsonian Disorders; Postoperative Complications; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2018 |
Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib.
Topics: Adult; Dasatinib; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2013 |
PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling.
Topics: Cell Differentiation; Cell Movement; Cell Proliferation; Chemokine CCL2; Collagen; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Molecular Targeted Therapy; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Platelet-Derived Growth Factor; PPAR delta; Pulmonary Artery; Thiazoles; Transcriptional Activation; Up-Regulation | 2013 |
[Reversible pulmonary hypertension as a consequence of dasatinib treatment in a patient with chronic myeloid leukemia and scleroderma].
Topics: Dasatinib; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Scleroderma, Systemic; Thiazoles | 2013 |
Idiopathic pulmonary arterial hypertension.
Topics: Aminorex; Antihypertensive Agents; Appetite Depressants; Bosentan; Dasatinib; Epoprostenol; Familial Primary Pulmonary Hypertension; Fenfluramine; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Iloprost; Phenylpropionates; Piperazines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyridazines; Pyrimidines; Risk Factors; Sildenafil Citrate; Sulfonamides; Sulfones; Thiazoles; Vasodilator Agents | 2013 |
Reversible pre-capillary pulmonary hypertension due to dasatinib.
Topics: Dasatinib; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Protein Kinase Inhibitors; Purines; Pyrimidines; Sildenafil Citrate; Sulfones; Thiazoles | 2014 |
Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.
Topics: Antineoplastic Agents; Dasatinib; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report.
Topics: Antineoplastic Agents; Dasatinib; Humans; Hypertension, Pulmonary; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thiazoles | 2015 |
Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
Topics: Adult; Antineoplastic Agents; Dasatinib; Drug Substitution; Echocardiography; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2015 |
Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Everolimus; Hypertension, Pulmonary; Male; Matrix Metalloproteinases; Monocrotaline; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Thiazoles; Vasodilator Agents | 2017 |
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Blotting, Western; Disease Models, Animal; Female; Humans; Hypertension, Pulmonary; Immunohistochemistry; Male; Nebivolol; Pulmonary Artery; Random Allocation; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, beta-3; Swine; Thiazoles; Vascular Resistance; Ventricular Remodeling | 2016 |
Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia.
Topics: Adult; Antineoplastic Agents; Dasatinib; Echocardiography; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Thiazoles | 2009 |
Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.
Topics: Dasatinib; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Pulmonary; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pyrimidines; Thiazoles; Transplantation, Homologous; Ventricular Dysfunction, Right | 2009 |
The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
Topics: Administration, Oral; Animals; Cardiomegaly; Hypertension, Pulmonary; Hypoxia; Lung; Male; Mice; Mice, Transgenic; PPAR delta; PPAR-beta; Rats; Rats, Wistar; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Thiazoles | 2010 |
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension.
Topics: Animals; Azabicyclo Compounds; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Hypertension, Pulmonary; Indoles; Lung; Male; Mice; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Telemetry; Tetrazolium Salts; Thiazoles; Thymidine; Treatment Outcome | 2010 |
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
Topics: Aged; Dasatinib; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Treatment Outcome | 2011 |
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia.
Topics: Antineoplastic Agents; Blood Pressure; Dasatinib; Familial Primary Pulmonary Hypertension; Hemodynamics; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pulmonary Medicine; Pyrimidines; Thiazoles; Treatment Outcome; Ventricular Dysfunction, Right | 2011 |
Whistleblowers.
Topics: Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Thiazoles | 2011 |
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.
Topics: Antineoplastic Agents; Dasatinib; Dose-Response Relationship, Drug; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pyrimidines; Remission, Spontaneous; Thiazoles; Time Factors | 2012 |
Dasatinib: pulmonary arterial hypertension. French data.
Topics: Antineoplastic Agents; Dasatinib; Familial Primary Pulmonary Hypertension; France; Humans; Hypertension, Pulmonary; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles | 2011 |
Double-edged sword of the new cancer therapeutics.
Topics: Antineoplastic Agents; Dasatinib; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2012 |
Pulmonary arterial hypertension in patients treated by dasatinib.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antineoplastic Agents; Benzamides; Bone Morphogenetic Protein Receptors, Type II; Calcium Channel Blockers; Dasatinib; Drug Utilization; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Hemodynamics; Humans; Hydroxyurea; Hypertension, Pulmonary; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Registries; Thiazoles; Treatment Outcome | 2012 |
Role of Src tyrosine kinases in experimental pulmonary hypertension.
Topics: Animals; Apoptosis; Becaplermin; Benzamides; Cell Proliferation; Cells, Cultured; Chemotaxis; Dasatinib; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Imatinib Mesylate; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Thiazoles; Time Factors | 2012 |
Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin A; DNA; GTP Phosphohydrolases; Hypertension, Pulmonary; Hypoxia; Lung; Male; Membrane Proteins; Mitochondrial Proteins; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; RNA, Small Interfering; Tetrazolium Salts; Thiazoles | 2012 |
Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.
Topics: Dasatinib; Echocardiography; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Protein Kinase Inhibitors; Purines; Pyrimidines; Sildenafil Citrate; Sulfones; Thiazoles; Treatment Outcome; Vasodilator Agents; Withholding Treatment | 2012 |
Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.
Topics: Animals; Anoctamin-1; Calcium Channel Blockers; Chloride Channel Agonists; Chloride Channels; Cyclooxygenase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indomethacin; Male; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; Niflumic Acid; Patch-Clamp Techniques; Pulmonary Artery; Pyrimidines; Rats; Rats, Wistar; Serotonin; Thiazoles | 2012 |
Endothelin-A receptor blockade in porcine pulmonary hypertension.
Topics: Animals; Blood Pressure; Carbon Dioxide; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Hypoxia; Infant, Newborn; NG-Nitroarginine Methyl Ester; Oligopeptides; Oxygen; Pulmonary Circulation; Receptor, Endothelin A; Streptococcal Infections; Streptococcus agalactiae; Sus scrofa; Thiazoles | 2002 |
Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Thiazoles | 1996 |
Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Topics: Administration, Oral; Animals; Calcium Channel Blockers; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Wistar; Thiazoles | 1995 |